Skip to main content
. 2018 May 18;9(38):25034–25047. doi: 10.18632/oncotarget.25244

Table 4. EGF-Receptor expression.

Patient Culture condition EGFR (%) Viability (%) Proliferation (%)
Day 0 Day 7 Day 7 Day 7
22 EGF 50 90 100 30 70
80 60 50
24 Hydrocortisone 80 70 70 10
40 80 60 25
26 Folic acid 6 80 70 30 30
80
29 EGF 50 50 20 50 30
40 10 90 2
30 EGF 50 90 10 50 0
90 5 30 30
73 EGF 50 100 80 70 10
90 5 30 0
74 EGF 50 95 40 30 30
50 40 20

Raw percentage of positive EGFR expression at day 0 and day 7.